Abstract

Cisplatin (cis-diamminedichloroplatinum) is widely used as a chemotherapeutic drug for genitourinary, breast, lung and head and neck cancers. Though effective in inducing apoptosis in cancer cells, cisplatin treatment causes severe hearing loss among patients. Steroids have been shown to mitigate cisplatin-induced hearing loss. However, steroids may interfere with the anti-cancer properties of cisplatin if administered systemically, or are rapidly cleared from the middle and inner ear and hence lack effectiveness when administered intra-tympanically. In this work, we deliver prednisolone-loaded nanoparticles magnetically to the cochlea of cisplatin-treated mice. This magnetic delivery method substantially reduced hearing loss in treated animals at high frequency compared to control animals or animals that received intra-tympanic methylprednisolone. The method also protected the outer hair cells from cisplatin-mediated ototoxicity.

Highlights

  • IntroductionCisplatin (cis-diamminedichloroplatinum) and other platinum based drugs are the antineoplastic drugs of choice for various genitourinary cancers, certain forms of breast cancers, and as radiosensitizers for most head and neck cancers

  • Cisplatin and other platinum based drugs are the antineoplastic drugs of choice for various genitourinary cancers, certain forms of breast cancers, and as radiosensitizers for most head and neck cancers

  • We show that magnetic steroid delivery to the inner ear can be used to protect hearing in mice receiving systemic cisplatin regimens

Read more

Summary

Introduction

Cisplatin (cis-diamminedichloroplatinum) and other platinum based drugs are the antineoplastic drugs of choice for various genitourinary cancers, certain forms of breast cancers, and as radiosensitizers for most head and neck cancers. The ototoxic effect of cisplatin is noticeable, with hearing loss within hours or days after the first cisplatin injection (Rybak et al, 2009). It is cumulative, and the cumulative effect implies particular vulnerability in pediatric populations as repeated treatments, even separated by years, eventually lead to complete hearing loss, which may in turn lead to pervasive developmental delays including speech, cognitive and social developmental challenges

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.